检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:肖佔华 李婧[1] XIAO Zhanhua;LI Jing(Departmen of Cardiovascular Medicine,Tianyou Hospital Affiliated to Wuhan University of Science and Technology,Wuhan,Hubei 430064,China)
机构地区:[1]武汉科技大学附属天佑医院心血管内科,湖北武汉430064
出 处:《安徽医药》2025年第5期882-887,共6页Anhui Medical and Pharmaceutical Journal
摘 要:阻塞性睡眠呼吸暂停综合征(OSAS)被认为是心血管疾病的独立危险因素,参与了心血管疾病的发生与发展,其对机体的损害常被低估。目前持续气道正压通气治疗(CPAP)是临床上首选的治疗方法。了解OSAS及CPAP干预治疗对心血管疾病的影响,加深对OSAS的认识有助于制定有效治疗策略、改善病人预后。现分别从OSAS对心血管疾病的影响和CPAP干预治疗OASA与心血管疾病风险的关系两方面进行综述,以期为OSAS相关心血管疾病的诊断和治疗提供文献基础和理论依据。Obstructive sleep apnea syndrome(OSAS)is considered to be an independent risk factor for cardiovascular diseases,which is involved in the occurrence and development of cardiovascular diseases,and its damage to the body is often underestimated.Continuous positive airway pressure(CPAP)is the preferred treatment in clinic.Fully understanding the impact of OSAS and CPAP intervention on cardiovascular diseases,deepening the understanding of OSAS is helpful to develop effective treatment strategies and improve the prognosis of patients.This paper reviews the impact of OSAS on cardiovascular diseases and the relationship between CPAP intervention on OASA and cardiovascular disease risk,so as to provide literature basis and theoretical basis for the diagnosis and treatment of OSAS related cardiovascular diseases.
关 键 词:睡眠呼吸暂停 阻塞性 持续气道正压通气 心血管疾病
分 类 号:R766[医药卫生—耳鼻咽喉科] R563.9[医药卫生—临床医学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.63